Products

Glytec Glucommander
Glytec, LLC
Clinical Decision Support & Reference
Glytec Glucommander is an FDA-cleared, AI-driven, cloud-based insulin management software that provides clinical decision support and personalized insulin dosing recommendations for both IV and subcutaneous insulin therapy in hospitals and health systems. It is part of the broader GlytecOne platform, which offers intelligent glycemic management solutions to improve patient safety, reduce complications, and drive better patient outcomes.

See all 1 product →

About Glytec

Glytec is a leading healthcare AI company specializing in intelligent glycemic management. Their flagship product, Glucommander®, is an FDA-cleared, cloud-based insulin dosing software that leverages real-time and historical patient data to provide personalized IV and subcutaneous insulin dosing recommendations for adult and pediatric patients (ages 2-17 years). This AI-powered platform aims to improve patient safety, reduce readmissions, and streamline clinical workflows in hospitals and health systems. Glytec’s solutions are designed to move beyond manual protocols and sliding-scale dosing, offering validated guidance to clinicians and supporting confident insulin management decisions.

For physicians, GlytecOne, the unified insulin management platform, offers several key benefits. It provides FDA-cleared point-of-care dosing guidance for both IV and subcutaneous insulin through Glucommander®, helping to reduce variability and support safer decisions at the bedside. The platform also includes Command Center, which offers current patient data displays to help identify emerging patterns and areas needing clinical review, as well as enterprise-level analytics for leaders to review trends and identify areas for improvement. Glytec’s system integrates with major electronic health record (EHR) platforms like Epic and Cerner, aiming to simplify workflows for providers, nurses, and pharmacists, and offering enhanced features for IV to SubQ insulin transition and hypoglycemia management. The company emphasizes that Intelligent Glycemic Management supports, rather than replaces, clinical judgment.

Focus Areas

AI-powered diabetes management insulin dosing software glycemic management clinical decision support workflow automation performance analytics population health intelligence inpatient and outpatient care.

Business Intelligence

Key InvestorsHayfin Capital Management, Savitr Capital, CalAtlantic Group, Sea Dragon Healthcare Partners, Silicon Valley Bank (SVB)
PartnershipsTidalHealth, CPS Solutions, LLC, Premier, Roche
TechnologyCloud-based SaaS solution, AI-powered technology platform, integrates with EHRs (Epic, Oracle Health (Cerner), Meditech), FDA-cleared Class II Software as a Medical Device (SaMD), HIPAA compliant, HITRUST certified
FDA Clearances4 cleared products (estimated)

What Physicians Need to Know

AI-Powered Insulin Dosing Software (Glucommanderu00ae)
Glytec's flagship product, Glucommanderu00ae, is an FDA-cleared, cloud-based software that provides personalized IV and subcutaneous insulin dosing recommendations for adult and pediatric (ages 2-17 years) patients. It uses real-time and historical patient data to learn insulin sensitivity and predict future needs, replacing outdated manual protocols and sliding-scale insulin.
Intelligent Glycemic Management Platform (GlytecOneu2122)
GlytecOne is a unified platform integrating clinical decision support, care workflow automation, performance analytics, and population health insights. It aims to deliver safer, smarter glucose management across the entire health system, from inpatient to outpatient settings.
Clinical Decision Support
The platform's Decision Support layer, including Command Center, organizes and displays current and retrospective patient glucose data and evidence-based information to support clinician awareness, prioritization, and informed clinical review. It's purpose-built for glucose management, reducing alert fatigue by presenting context-specific data.
Workflow Automation
GlytecOne streamlines clinical workflows by automating time-consuming, error-prone steps in glycemic protocol management. This includes automated protocol workflow and documentation support, pharmacy-integrated order review tools, and built-in audit trails. It also offers features like single sign-on (SmartClicku2122) and automated reminders for blood glucose checks.
Performance Analytics (GlucoMetricsu00ae)
Glytec's Performance Insights, delivered through Command Center and GlucoMetricsu00ae, provide enterprise-level analytics and performance intelligence. It aggregates glycemic data across the health system, offering actionable dashboards, benchmarks, and improvement roadmaps, including KPI dashboards, automated benchmarking, and eCQM-aligned reporting modules for CMS compliance.
Population Health Intelligence
GlytecOne's Population Health solution aggregates outcomes for all facilities and care settings, providing enterprise-wide glycemic performance intelligence. This supports systemic improvements in glycemic management at scale across the entire health system, including eCQM alignment, value-based care reporting, and health plan partnerships.
Inpatient and Outpatient Care
Glytec's solutions support glycemic management across the continuum of care, including IV, subcutaneous (SubQ), and outpatient insulin management, as well as transitions between these stages.
Physician Tip

Glytec's Glucommanderu00ae offers personalized, evidence-based insulin dosing recommendations, reducing the burden of manual calculations and minimizing errors. The system provides real-time visibility into patient glucose data through Command Center, helping physicians prioritize and make informed decisions. Workflow automation and EHR integration streamline documentation and reduce administrative tasks, freeing up time for direct patient care. The platform's analytics capabilities (GlucoMetricsu00ae) allow for tracking key performance indicators and identifying areas for improvement in glycemic control across patient populations, which is crucial for value-based care and CMS compliance. Glytec's solutions have demonstrated significant reductions in severe hypoglycemia, length of stay, and readmissions.

GlytecOne is designed for seamless, bi-directional integration with major Electronic Health Record (EHR) systems, including Epic, Oracle Health (Cerner), and Meditech. This integration ensures clinical data flows cleanly, documentation remains within the EHR, and reduces the need for duplicate data entry. The platform utilizes an HL7 interface for standard data exchange protocols.

Products by Glytec

1 product in the directory

Glytec Glucommander
Glytec, LLC
Clinical Decision Support & Reference
Glytec Glucommander is an FDA-cleared, AI-driven, cloud-based insulin management software that provides clinical decision support and personalized insulin dosing recommendations for both IV and subcutaneous insulin therapy in hospitals and health systems. It is part of the broader GlytecOne platform, which offers intelligent glycemic management solutions to improve patient safety, reduce complications, and drive better patient outcomes.

What the Web Says

Glytec is a healthcare technology company specializing in insulin management software for hospitals and health systems. Their flagship product, Glucommander, is an FDA-cleared, AI-powered platform designed to optimize insulin dosing, reduce glycemic events, and improve patient safety. While there are limited recent reviews on major platforms like G2, Glassdoor, and Capterra specifically for Glytec, available information suggests a positive impact on clinical outcomes and workflow efficiency. Employer reviews are mixed, with some highlighting a productive environment and challenging work, while others point to areas for improvement in management, culture, and benefits.

Overall: Mixed

Strengths

  • Improved patient safety and insulin dosing accuracy with Glucommander
  • Reduced hypoglycemic events
  • Streamlined nursing workflows and enhanced documentation accuracy through EHR integration
  • Challenging and active work environment
  • Good team and quick-paced environment (older reviews)
  • Free coffee, iced tea, and snacks (older reviews)

Limitations

  • Benefits need significant improvement (older employer review)
  • Management and culture rated lower in older employer reviews
  • Job security and advancement rated lower in older employer reviews
  • Process improvement needed (older employer review)
  • Limited recent product reviews on major platforms like G2 and Capterra
  • No specific Glytec reviews found on Reddit for products or employer

Based on reviews from: Indeed.com, SimplyHired, Elion Health, KLAS Research, Zippia, ADCES, PubMed, The Leapfrog Group

Last updated: 2026-06-23

Videos

News, demos, and interviews about Glytec.

Loading videos...

Videos load interactively. If none appear, search YouTube for Glytec →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Glytec's core product is GlytecOne, an intelligent glycemic management platform. At its heart is Glucommander, an FDA-cleared, AI-powered insulin dosing software that provides personalized IV and subcutaneous insulin recommendations. It uses real-time and historical patient data to learn insulin sensitivity and predict future needs, aiming to reduce errors and improve patient outcomes.
GlytecOne offers a unified platform for both inpatient and outpatient care, integrating clinical decision support, workflow automation, and performance analytics. For clinicians, it provides algorithm-based insulin dosing guidance, automated protocol workflows, and pharmacy-integrated order review tools, which streamline processes and reduce manual errors. The system also offers current patient visibility and structured clinical review through its Command Center, helping clinicians make informed decisions.
GlytecOne includes Performance Insights and Population Health intelligence. Performance Insights, delivered via the Command Center, provides enterprise analytics, benchmarking, and eCQM-aligned reporting to measure and improve glycemic performance across the health system. Population Health aggregates glycemic data, outcomes, and analytics across all facilities and care settings, offering enterprise-level intelligence for managing outcomes, regulatory compliance, and financial performance.
Glytec's Glucommander is an FDA-cleared Class II Software as a Medical Device (SaMD), ensuring rigorous testing and validation. The entire GlytecOne platform is HIPAA compliant and HITRUST certified, meaning it adheres to strict information security and risk management requirements to protect patient data.
Glytec offers 24/7 clinical and technical support for Severity 1 issues, with routine support available during business hours for other issues. The company has been recognized as a top diabetes management platform and has secured significant growth investments, indicating strong company stability. Glytec also has strategic partnerships with health systems like TidalHealth and Ardent Health, and collaborations with companies like Roche, to expand its reach and integrate its solutions.
While specific pricing details are not publicly disclosed, annual licensing fees for Glytec's platform typically include software implementation, team training, and ongoing technical and clinical support.
Glytec's solutions are designed to help hospitals meet the upcoming CMS glycemic management mandates, which begin in fiscal year 2026 (October 1, 2025). Their platform provides advanced analytics for actionable insights and eCQM-aligned reporting to support compliance with these new mandatory electronic clinical quality measures (eCQMs).

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.